Fundraising Fox
Royalty Pharma
NASDAQ: RPRXNew York, US · Founded 1996 · 114 employees on LinkedIn · 3 known investors
Find your way into Royalty Pharma
Sign up to see every warm intro you have to Royalty Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Royalty Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Royalty Pharma acquires and manages pharmaceutical royalties from approved drugs and therapies, providing investors exposure to the biopharma sector without early-stage development risk. The company operates as a market leader in the pharmaceutical royalty market with a diversified portfolio of long-duration revenue streams.
Founders & leadership
Investors · 3
Frequently asked questions
- What does Royalty Pharma do?
- Royalty Pharma acquires and manages pharmaceutical royalties from approved drugs and therapies, providing investors exposure to the biopharma sector without early-stage development risk. The company operates as a market leader in the pharmaceutical royalty market with a diversified portfolio of long-duration revenue streams.
- Who are Royalty Pharma's investors?
- Royalty Pharma's investors include General Atlantic, Paladin Capital Group, Scientia Ventures.
- Where is Royalty Pharma headquartered?
- Royalty Pharma is headquartered in New York, US.